"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 5 | 3 | 8 |
| 2003 | 7 | 5 | 12 |
| 2004 | 5 | 1 | 6 |
| 2005 | 5 | 4 | 9 |
| 2006 | 5 | 3 | 8 |
| 2007 | 4 | 4 | 8 |
| 2008 | 9 | 6 | 15 |
| 2009 | 6 | 5 | 11 |
| 2010 | 12 | 4 | 16 |
| 2011 | 12 | 6 | 18 |
| 2012 | 13 | 3 | 16 |
| 2013 | 10 | 4 | 14 |
| 2014 | 17 | 8 | 25 |
| 2015 | 20 | 11 | 31 |
| 2016 | 11 | 9 | 20 |
| 2017 | 13 | 5 | 18 |
| 2018 | 20 | 8 | 28 |
| 2019 | 22 | 7 | 29 |
| 2020 | 27 | 3 | 30 |
| 2021 | 16 | 6 | 22 |
| 2022 | 25 | 0 | 25 |
| 2023 | 28 | 1 | 29 |
| 2024 | 16 | 6 | 22 |
| 2025 | 9 | 4 | 13 |
| 2026 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea. Blood. 2026 May 07; 147(19):2215-2225.
-
Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2026 Apr 28; 10(8):2698-2710.
-
MHC class I on target cells regulates CD4+ T cell-mediated immunity. Nat Immunol. 2026 May; 27(5):1000-1012.
-
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. Blood Adv. 2026 Mar 24; 10(6):1979-1991.
-
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant. Pediatr Blood Cancer. 2026 Jun; 73(6):e70259.
-
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. J Clin Oncol. 2026 Apr 10; 44(11):1003-1015.
-
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
-
Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells. J Clin Invest. 2025 Dec 15; 135(24).
-
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease. Blood. 2025 Oct 23; 146(17):2047-2062.
-
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplant Cell Ther. 2025 Oct; 31(10):826.e1-826.e10.